Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope

被引:34
|
作者
Wu, Lan
Yang, Zhi-Yong
Xu, Ling
Welcher, Brent
Winfrey, Sarah
Shao, Yiming
Mascola, John R.
Nabel, Gary J.
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] China CDC, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China
关键词
HIV-1; envelope; neutralizing antibodies;
D O I
10.1016/j.vaccine.2006.03.083
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To understand the cross-reactivity of antibodies directed against variable regions of human immunodeficiency virus-1 (HIV-1) envelope (Env), chimeric immunogens were prepared from different clades with modifications in variable regions, and the resulting neutralizing antibody response was evaluated. The V3-specific neutralization activity induced by a clade B immunogen was limited to clade B viruses and was blocked by a clade B V3 peptide, but not by analogous clade A or C V3 peptides. In contrast, the V3 response elicited by a clade C immunogen cross-reacted with sensitive clade B viruses. The V3 region from a clade C virus, when introduced into a clade B sequence, elicited cross-clade activity, which could be reversed by V3 peptides derived from clades A and C. Thus, the anti-V3 antibody response elicited by a clade C immunogen could cross-react with heterologous clade viruses. Additionally, we describe a V I-specific immune response that mediated neutralization limited to the homologous HIV IIIB isolate and may be partially responsible for the commonly observed strain-specific neutralization responses elicited by vaccine immunogens. Published by Elsevier Ltd.
引用
收藏
页码:4995 / 5002
页数:8
相关论文
共 50 条
  • [21] Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1
    Gorny, Miroslaw K.
    Williams, Constance
    Volsky, Barbara
    Revesz, Kathy
    Wang, Xiao-Hong
    Burda, Sherri
    Kimura, Tetsuya
    Konings, Frank A. J.
    Nadas, Arthur
    Anyangwe, Christopher A.
    Nyambi, Phillipe
    Krachmarov, Chavdar
    Pinter, Abraham
    Zolla-Pazner, Susan
    JOURNAL OF VIROLOGY, 2006, 80 (14) : 6865 - 6872
  • [22] ALTERATION OF V3 LOOP CONTEXT WITHIN THE ENVELOPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENHANCES NEUTRALIZATION
    ROBERTGUROFF, M
    LOUIE, A
    MYAGKIKH, M
    MICHAELS, F
    KIENY, MP
    WHITESCHARF, ME
    POTTS, B
    GROGG, D
    REITZ, MS
    JOURNAL OF VIROLOGY, 1994, 68 (06) : 3459 - 3466
  • [23] A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1
    Stiegler, G
    Kunert, R
    Purtscher, M
    Wolbank, S
    Voglauer, R
    Steindl, F
    Katinger, H
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (18) : 1757 - 1765
  • [24] An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV
    Watkins, Jennifer D.
    Siddappa, Nagadenahalli B.
    Lakhashe, Samir K.
    Humbert, Michael
    Sholukh, Anton
    Hemashettar, Girish
    Wong, Yin Ling
    Yoon, John K.
    Wang, Wendy
    Novembre, Francis J.
    Villinger, Francois
    Ibegbu, Chris
    Patel, Kalpana
    Corti, Davide
    Agatic, Gloria
    Vanzetta, Fabrizia
    Bianchi, Siro
    Heeney, Jonathan L.
    Sallusto, Federica
    Lanzavecchia, Antonio
    Ruprecht, Ruth M.
    PLOS ONE, 2011, 6 (03):
  • [25] Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B′ strains by recombinant Mycobacterium bovis BCG-based candidate vaccine
    Chujoh, Y
    Matsuo, K
    Yoshizaki, H
    Nakasatomi, T
    Someya, K
    Okamoto, Y
    Naganawa, S
    Haga, S
    Yoshikura, H
    Yamazaki, A
    Yamazaki, S
    Honda, M
    VACCINE, 2001, 20 (5-6) : 797 - 804
  • [26] Envelope variants from women recently infected with clade A human immunodeficiency virus type 1 confer distinct phenotypes that are discerned by competition and neutralization experiments
    Painter, SL
    Biek, R
    Holley, DC
    Poss, M
    JOURNAL OF VIROLOGY, 2003, 77 (15) : 8448 - 8461
  • [27] Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection (vol 81, pg 1350, 2007)
    Rong, Rong
    Bibollet-Ruche, Frederic
    Mulenga, Joseph
    Allen, Susan
    Blackwell, Jerry L.
    Derdeyn, Cynthia A.
    JOURNAL OF VIROLOGY, 2007, 81 (22) : 12715 - 12715
  • [28] Generation and characterization of human monoclonal single chain variable fragments (scFvs) against envelope third variable region (V3) of HIV-1 clade C
    Rajesh Kumar
    Raiees Andrabi
    Ashutosh Tiwari
    Somi Sankaran Prakash
    Naveet Wig
    Durgashree Dutta
    Anurag Sankhyan
    Lubina Khan
    Subrata Sinha
    Kalpana Luthra
    BMC Infectious Diseases, 12 (Suppl 1)
  • [29] The tat and C2-V3 envelope genes in the molecular epidemiology of human immunodeficiency virus-1
    Lorenzo, E
    Herrera, RJ
    Lai, SH
    Fischl, MA
    Hill, MD
    VIROLOGY, 1996, 221 (02) : 310 - 317
  • [30] Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa
    Bures, R
    Morris, L
    Williamson, C
    Ramjee, G
    Deers, M
    Fiscus, SA
    Abdool Karim, SS
    Montefiori, DC
    JOURNAL OF VIROLOGY, 2002, 76 (05) : 2233 - 2244